Catalyst Capital Advisors Has Lowered Brandywine Rlty Tr (BDN) Stake By $963,200; Bvf Has Lowered Its Cytokinetics (CYTK) Stake

Catalyst Capital Advisors Llc decreased Brandywine Rlty Tr (BDN) stake by 62.13% reported in 2016Q4 SEC filing. Catalyst Capital Advisors Llc sold 60,200 shares as Brandywine Rlty Tr (BDN)’s stock rose 8.05%. The Catalyst Capital Advisors Llc holds 36,700 shares with $606,000 value, down from 96,900 last quarter. Brandywine Rlty Tr now has $2.94B valuation. The stock rose 2.52% or $0.42 reaching $17.07. About 1.47M shares traded or 27.83% up from the average. Brandywine Realty Trust (NYSE:BDN) has risen 8.97% since October 3, 2016 and is uptrending. It has underperformed by 1.94% the S&P500.

Bvf Inc decreased Cytokinetics Inc (CYTK) stake by 2.91% reported in 2016Q4 SEC filing. Bvf Inc sold 145,380 shares as Cytokinetics Inc (CYTK)’s stock rose 32.93%. The Bvf Inc holds 4.85M shares with $58.95M value, down from 5.00 million last quarter. Cytokinetics Inc now has $588.05M valuation. The stock declined 0.17% or $0.03 reaching $14.27 per share. About 167,487 shares traded. Cytokinetics, Inc. (NASDAQ:CYTK) has risen 56.46% since October 3, 2016 and is uptrending. It has outperformed by 45.55% the S&P500.

Catalyst Capital Advisors Llc increased Pnc Finl Svcs Group Inc (NYSE:PNC) stake by 7,500 shares to 15,400 valued at $1.80M in 2016Q4. It also upped C H Robinson Worldwide Inc (NASDAQ:CHRW) stake by 51,798 shares and now owns 53,048 shares. Edison Intl (NYSE:EIX) was raised too.

Analysts await Brandywine Realty Trust (NYSE:BDN) to report earnings on July, 19. They expect $0.34 EPS, up 6.25% or $0.02 from last year’s $0.32 per share. BDN’s profit will be $58.56M for 12.55 P/E if the $0.34 EPS becomes a reality. After $0.32 actual EPS reported by Brandywine Realty Trust for the previous quarter, Wall Street now forecasts 6.25% EPS growth.

Among 12 analysts covering Brandywine Realty Trust (NYSE:BDN), 6 have Buy rating, 1 Sell and 5 Hold. Therefore 50% are positive. Brandywine Realty Trust had 19 analyst reports since August 14, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Friday, September 4 by Barclays Capital. The rating was downgraded by Argus Research to “Hold” on Friday, November 6. The stock of Brandywine Realty Trust (NYSE:BDN) earned “Buy” rating by Stifel Nicolaus on Friday, April 21. Mizuho downgraded the stock to “Neutral” rating in Friday, July 22 report. Raymond James upgraded the shares of BDN in report on Monday, January 9 to “Outperform” rating. As per Friday, September 4, the company rating was upgraded by Zacks. Zacks upgraded Brandywine Realty Trust (NYSE:BDN) on Friday, August 14 to “Sell” rating. On Tuesday, July 19 the stock rating was maintained by Barclays Capital with “Equalweight”. The stock of Brandywine Realty Trust (NYSE:BDN) earned “Buy” rating by Evercore on Monday, December 19. BB&T Capital initiated Brandywine Realty Trust (NYSE:BDN) rating on Friday, November 13. BB&T Capital has “Buy” rating and $16.5 target.

Investors sentiment increased to 0.95 in Q4 2016. Its up 0.11, from 0.84 in 2016Q3. It improved, as 27 investors sold BDN shares while 70 reduced holdings. 29 funds opened positions while 63 raised stakes. 165.62 million shares or 10.09% less from 184.21 million shares in 2016Q3 were reported. Qs Investors Lc invested in 0% or 23 shares. State Street has invested 0.01% of its portfolio in Brandywine Realty Trust (NYSE:BDN). 272,423 are held by Strs Ohio. 769,720 were accumulated by Foundry Prtnrs Ltd Liability Company. Putnam Invests Ltd Liability reported 405,486 shares. Indexiq Advsrs Limited Co stated it has 166,563 shares. Princeton Alpha Management Lp stated it has 42,460 shares or 0.14% of all its holdings. Systematic Management Limited Partnership holds 886,375 shares or 0.23% of its portfolio. Cipher LP reported 0.04% stake. Northern Corp reported 1.70M shares. Neuberger Berman Ltd Liability Com reported 0.01% in Brandywine Realty Trust (NYSE:BDN). State Of Wisconsin Investment Board invested in 0.01% or 93,227 shares. Heitman Real Ltd Liability Corp stated it has 1.79% of its portfolio in Brandywine Realty Trust (NYSE:BDN). Teachers Annuity Association Of America holds 0.1% or 183,336 shares. Bnp Paribas Inv Prns Sa holds 0.21% of its portfolio in Brandywine Realty Trust (NYSE:BDN) for 1.34 million shares.

Since January 18, 2017, it had 1 insider buy, and 3 sales for $871,626 activity. On Monday, January 23 SWEENEY GERARD H sold $330,378 worth of Brandywine Realty Trust (NYSE:BDN) or 20,000 shares. 7,500 shares valued at $119,868 were bought by HAVERSTICK H RICHARD JR on Wednesday, February 8.

Analysts await Cytokinetics, Inc. (NASDAQ:CYTK) to report earnings on July, 27. They expect $-0.67 earnings per share, down 131.03% or $0.38 from last year’s $-0.29 per share. After $-0.62 actual earnings per share reported by Cytokinetics, Inc. for the previous quarter, Wall Street now forecasts 8.06% negative EPS growth.

Investors sentiment decreased to 1.08 in 2016 Q4. Its down 0.08, from 1.16 in 2016Q3. It worsened, as 8 investors sold CYTK shares while 30 reduced holdings. 17 funds opened positions while 24 raised stakes. 26.15 million shares or 1.34% less from 26.51 million shares in 2016Q3 were reported. Fortaleza Asset Mgmt Inc holds 20,560 shares or 0.53% of its portfolio. Schwab Charles Invest Mgmt Inc reported 127,442 shares. Airain reported 21,800 shares. Tower (Trc) holds 0% of its portfolio in Cytokinetics, Inc. (NASDAQ:CYTK) for 476 shares. Howe And Rusling, a New York-based fund reported 190 shares. Blackrock Mngmt Limited Company has invested 0% of its portfolio in Cytokinetics, Inc. (NASDAQ:CYTK). Ironwood Management Ltd Co stated it has 121,360 shares or 1.08% of all its holdings. Federated Investors Inc Pa holds 0% of its portfolio in Cytokinetics, Inc. (NASDAQ:CYTK) for 483 shares. Goldman Sachs Grp Inc has 71,491 shares for 0% of their portfolio. Deutsche State Bank Ag holds 97,705 shares. Sg Americas Secs Limited Liability Com owns 15,551 shares or 0% of their US portfolio. Blackrock accumulated 0% or 3,252 shares. Fmr Limited Liability Company holds 0.01% or 5.20 million shares in its portfolio. Wells Fargo & Mn invested in 0% or 26,766 shares. Globeflex Limited Partnership reported 139,065 shares.

Bvf Inc increased Immune Design Corp (NASDAQ:IMDZ) stake by 120,164 shares to 1.32 million valued at $7.26 million in 2016Q4. It also upped Esperion Therapeutics Inc Ne (NASDAQ:ESPR) stake by 218,898 shares and now owns 712,770 shares. Aduro Biotech Inc was raised too.